• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Genetic Analysis

0.64 NOK

Less than 1K followers

GEAN

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-1.54 %
-0.62 %
+4.92 %
-8.57 %
-12.93 %
-34.69 %
-62.35 %
-
-94.02 %

Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.

Read more
Market cap
44.22M NOK
Turnover
-
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
28.8.
2026

Interim report Q2'26

26.11.
2026

Interim report Q3'26

25.2.
2027

Annual report '26

Regulatory press release5/28/2026, 6:45 AM

Publication of interim report January - March 2026

Genetic Analysis
Regulatory press release5/20/2026, 3:00 PM

Genetic Analysis AS: Minutes of Annual General Meeting

Genetic Analysis
Regulatory press release5/7/2026, 8:00 AM

Genetic Analysis AS: Genetic Analysis granted a U.S. patent for companion diagnostic related to IBS treatment response

Genetic Analysis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release5/5/2026, 7:00 AM

Genetic Analysis AS: Notice of annual general meeting

Genetic Analysis
Regulatory press release5/4/2026, 12:30 PM

Genetic Analysis AS publishes Annual Report 2025

Genetic Analysis
Press release4/30/2026, 8:00 AM

Genetic Analysis AS: Genetic Analysis to attend DDW congress in Chicago

Genetic Analysis
Regulatory press release3/12/2026, 7:00 AM

Genetic Analysis AS launches AInsight for AI-assisted interpretation of GA-map® Dysbiosis Test results

Genetic Analysis
Regulatory press release2/27/2026, 7:45 AM

Genetic Analysis AS: Publication of year-end report 2025

Genetic Analysis
Regulatory press release2/26/2026, 3:10 PM

Genetic Analysis AS: Clarification regarding the publication date of the year-end report 2025

Genetic Analysis
Regulatory press release2/19/2026, 7:00 AM

Genetic Analysis AS further strengthens IP portfolio with patent approval in the United States

Genetic Analysis
Regulatory press release2/12/2026, 8:00 AM

Genetic Analysis AS: Microbiome Dx Genetic Analysis announces important patent approval enhancing the use of GA-map® in Canada

Genetic Analysis
Regulatory press release11/27/2025, 7:00 AM

Genetic Analysis AS: Publication of interim report Q3 2025

Genetic Analysis
Regulatory press release11/17/2025, 7:00 AM

Genetic Analysis AS announces milestone in the IBD diagnostic test development project - completion of biomarker panel for GA-map® IBD Precision Dx

Genetic Analysis
Regulatory press release9/24/2025, 6:00 AM

Genetic Analysis AS launches the GA-map® MHI GutHealth reagent kit

Genetic Analysis
Regulatory press release8/27/2025, 6:00 AM

Genetic Analysis AS: Publication of Half-year report 2025

Genetic Analysis
Regulatory press release7/29/2025, 6:30 AM

Genetic Analysis AS and Pangea Laboratory LLC announces the launch of GA-map® MHI GutHealth in the USA

Genetic Analysis
Regulatory press release6/27/2025, 1:10 PM

Genetic Analysis AS: Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis
Regulatory press release6/18/2025, 8:40 AM

Genetic Analysis AS: Genetic Analysis announces final outcome of the subsequent offering to existing shareholders

Genetic Analysis
Regulatory press release6/18/2025, 7:30 AM

Genetic Analysis AS: Genetic Analysis: Direct issue has now been registered with the Norwegian Register of Business Enterprises

Genetic Analysis
Regulatory press release6/16/2025, 2:30 PM

Genetic Analysis AS: Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders

Genetic Analysis